Capricorn Venture Partners
Leuven · Series A–Late Stage · 24 people tracked
Investment thesis
Capricorn Partners identifies and invests in innovative companies leveraging technology as a competitive advantage, with particular focus on those creating positive global impact. The firm concentrates its investment strategy on three core technology areas: digital, health, and clean technologies, primarily targeting growth opportunities within Europe and the Benelux region.
Source: firm website, verified Jul 17, 2026.
Team · 24 people
from the firm's websiteCo-founder of Capricorn Venture Partners in 1993 and non-executive chairman overseeing the firm's strategic direction and remuneration policies.
Executive director at Capricorn Partners involved in investment and management operations.
Executive director at Capricorn Partners involved in investment and management operations.
Executive director at Capricorn Partners involved in investment and management operations.
Non-executive director serving on the audit and risk committee at Capricorn Partners.
Independent board member participating in the remuneration and nomination committee.
Independent board member responsible for audit and risk oversight at Capricorn Partners.
Independent director serving on the audit and risk committee at Capricorn Partners.
Investments · 16 tracked
- Aestuarium
- BlueBee
- Capricorn Healthtech Fund
- Cartagenia
- DAB.bio
- EclecticIQ
- Endo Tools Therapeutics
- EQT Life Sciences
- ExCulture
- Finquest
- Fruitcore Robotics
- Icometrix
- Minze
- Norbit
- Ogeda
- Spectricity
Frequently asked questions
- What stage does Capricorn Venture Partners invest at?
- Capricorn Venture Partners invests at the Series A, Series B, Growth, Late Stage stages.
- What sectors does Capricorn Venture Partners focus on?
- Capricorn Venture Partners focuses on Cleantech, Cloud Computing, Digital Health.
- Where is Capricorn Venture Partners located?
- Capricorn Venture Partners is headquartered in Leuven, BE.
Similar investors
A deep technology venture capital firm investing in companies solving major global challenges across climate change, human health, defense, security, space, and physically intensive industries.
Dot Capital is a New York City-based boutique venture capital firm founded in 2012 that invests in disruptive growth companies across technology sub-sectors including SaaS, mobile, Internet infrastructure, big data, IoT, digital media, and sharing economy platforms.
Oak is a multi-stage venture capital firm investing in high-growth opportunities across information technology, internet, consumer, financial services technology, healthcare information and services, and clean energy sectors. The firm has deployed approximately $9 billion across over 525 companies globally since its founding.
Osage University Partners invests in breakthrough startups emerging from leading research labs and innovation ecosystems, with a focus on tech and life science companies. The firm manages $800 million and has 150+ portfolio companies across all investment stages from pre-seed to crossover.
EQT Life Sciences, formerly known as LSP, is one of Europe's largest life sciences investors with a 30-year track record. The firm targets innovative companies developing therapeutics, medical devices, diagnostics, and healthtech solutions globally, backed by a team of experienced medical, scientific, and industry professionals.